Secondary analysis of the RESPOND trial (n=234) of MBCT plus usual care vs usual care in difficult-to-treat depression: baseline severity did not moderate MBCT's effect; gains in decentering partially mediated symptom improvement at 34 weeks.
Secondary analysisn = 234
Barnhofer et al. Mechanisms of mindfulness-based cognitive therapy in difficult-to-treat depression: moderation and mediation analyses from the RESPOND trial